142 related articles for article (PubMed ID: 32451851)
1. The Absence of PDR16 Gene Restricts the Overexpression of CaSNQ2 Gene in the Presence of Fluconazole in Candida albicans.
Bencova A; Goffa E; Morvova M; Valachovic M; Griač P; Toth Hervay N; Gbelska Y
Mycopathologia; 2020 Jun; 185(3):455-465. PubMed ID: 32451851
[TBL] [Abstract][Full Text] [Related]
2. PDR16-mediated azole resistance in Candida albicans.
Saidane S; Weber S; De Deken X; St-Germain G; Raymond M
Mol Microbiol; 2006 Jun; 60(6):1546-62. PubMed ID: 16796687
[TBL] [Abstract][Full Text] [Related]
3. The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans.
Znaidi S; De Deken X; Weber S; Rigby T; Nantel A; Raymond M
Mol Microbiol; 2007 Oct; 66(2):440-52. PubMed ID: 17897373
[TBL] [Abstract][Full Text] [Related]
4. The yeast Saccharomyces cerevisiae Pdr16p restricts changes in ergosterol biosynthesis caused by the presence of azole antifungals.
Šimová Z; Poloncová K; Tahotná D; Holič R; Hapala I; Smith AR; White TC; Griač P
Yeast; 2013 Jun; 30(6):229-41. PubMed ID: 23606207
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.
Mukherjee PK; Chandra J; Kuhn DM; Ghannoum MA
Infect Immun; 2003 Aug; 71(8):4333-40. PubMed ID: 12874310
[TBL] [Abstract][Full Text] [Related]
7. Azole susceptibility and transcriptome profiling in Candida albicans mitochondrial electron transport chain complex I mutants.
Sun N; Fonzi W; Chen H; She X; Zhang L; Zhang L; Calderone R
Antimicrob Agents Chemother; 2013 Jan; 57(1):532-42. PubMed ID: 23147730
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of mutations in transcription factors of efflux pump genes in fluconazole-resistant Candida albicans strains overexpressing the efflux pumps].
Kalkandelen KT; Doluca Dereli M
Mikrobiyol Bul; 2015 Oct; 49(4):609-18. PubMed ID: 26649419
[TBL] [Abstract][Full Text] [Related]
9. Azole resistance in a
Khandelwal NK; Chauhan N; Sarkar P; Esquivel BD; Coccetti P; Singh A; Coste AT; Gupta M; Sanglard D; White TC; Chauvel M; d'Enfert C; Chattopadhyay A; Gaur NA; Mondal AK; Prasad R
J Biol Chem; 2018 Jan; 293(2):412-432. PubMed ID: 29158264
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.
Henry KW; Cruz MC; Katiyar SK; Edlind TD
Antimicrob Agents Chemother; 1999 Aug; 43(8):1968-74. PubMed ID: 10428921
[TBL] [Abstract][Full Text] [Related]
11. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole.
Calabrese D; Bille J; Sanglard D
Microbiology (Reading); 2000 Nov; 146 ( Pt 11)():2743-2754. PubMed ID: 11065353
[TBL] [Abstract][Full Text] [Related]
12. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
Coste AT; Ramsdale M; Ischer F; Sanglard D
Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058
[TBL] [Abstract][Full Text] [Related]
13. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.
Sanglard D; Ischer F; Monod M; Bille J
Antimicrob Agents Chemother; 1996 Oct; 40(10):2300-5. PubMed ID: 8891134
[TBL] [Abstract][Full Text] [Related]
14. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
[TBL] [Abstract][Full Text] [Related]
15. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
Sanglard D; Ischer F; Monod M; Bille J
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
[TBL] [Abstract][Full Text] [Related]
16. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
Smith WL; Edlind TD
Antimicrob Agents Chemother; 2002 Nov; 46(11):3532-9. PubMed ID: 12384361
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
19. The fungicide fludioxonil antagonizes fluconazole activity in the human fungal pathogen Candida albicans.
Buschart A; Burakowska A; Bilitewski U
J Med Microbiol; 2012 Dec; 61(Pt 12):1696-1703. PubMed ID: 22918865
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of the PDR16 promoter in a Candida albicans azole-resistant clinical isolate overexpressing CDR1 and CDR2.
De Deken X; Raymond M
Antimicrob Agents Chemother; 2004 Jul; 48(7):2700-3. PubMed ID: 15215129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]